News
Eli Lilly has rolled out a prefilled pen version of its weight-loss drug Mounjaro at the same price as vials, aiming to ...
2h
Zacks Investment Research on MSNNovo Nordisk Rises 6% So Far in August: How to Play the Stock
Novo Nordisk NVO faced a significant setback in July after sharply reducing its 2025 outlook for both sales and operating ...
Novo Nordisk has plummeted back to Earth after a stunning rise driven by Ozempic and Wegovy. Can the storied Danish pharma ...
Eli Lilly on Wednesday launched the easy-to-use injector pen of its blockbuster weight-loss drug Mounjaro for 14,000 rupees ...
Enthusiasm for its weight loss medications is intensifying, and several companies are preparing oral formulations.
Parker Waichman, a national law firm, has now filed five (5) separate lawsuits where each Plaintiff alleged that he or she developed NAION after taking ...
This article covers key health news including Primary Health Properties securing a takeover bid for Assura, Novo Nordisk's ...
The Mounjaro KwikPen, a multi-dose, prefilled device for single-patient use, is designed for convenient self-administration.
Eli Lilly has launched its Mounjaro KwikPen in India at ₹14,000 for the 2.5 mg dose; the once-weekly injector targets ...
Parker Waichman, a national law firm, along with four other law firms, asks the New Jersey Supreme Court to Centralize all Ozempic/Wegovy NAION New Jersey ...
5hon MSNOpinion
200% opportunity NOW: How Novo Nordisk, Dryden Gold, and Puma could boost your portfolio
The stock market in 2025 resembles a chessboard of extremes. While volatility is shaking up markets, extraordinary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results